Latest National Institute of Allergy and Infectious Diseases Stories
Inflamax Research today announces a collaboration with the Immune Tolerance Network (ITN), which is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US
Baylor College of Medicine researchers will lead a three-year, $4.2 million study funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to determine whether drugs called beta blockers can ease airway narrowing in patients with asthma and examine potential mechanisms.
National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.
National Institutes of Health (NIH) researchers have developed a model of infection in rhesus macaques that will help scientists around the world better understand how an emerging coronavirus, first identified in September 2012, affects people.
AIDS research has come a long way since the disease was first clinically discovered in 1981 and officially named by the US Centers for Disease Control and Prevention (CDC) in 1982. And although many hurdles had been overcome in the prevention and treatment of the world’s deadliest sexually-transmitted infection (STI) over the past thirty years, no real cure had ever been found.
- A trick or prank.